FDA recalls 581,000 blood pressure medication over cancer-causing chemicals

The United States Food and Drug Administration (FDA) has recalled a blood pressure medication over concerns it contains potentially cancer causing chemicals. The medication is used to treat high blood pressure.

FDA classified the medication as Class II risk level on October 24 and recalled more than half million bottles (5,81,000) after tests showed that it contained cancer-causing chemicals above the acceptable safety limits.

Class II risk means that usage or exposure to the medication may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Teva Pharmaceuticals issued a voluntary recall for their product, prazosin hydrochloride, - on October 7, 2025.

Other medications included in the recall include:

• The recall includes 181,659 bottles of the 1 mg capsules linked to lot numbers 3010544A and 3010545A, both carrying October 2025 expiration dates.
• The 2 mg version accounts for the biggest share of the recall, with about 291,512 bottles pulled from shelves. These were distributed under NDC codes 0093-4068-01 and 0093-4068-10 and come from a range of production lots expiring between October 2025 and July 2026.
• Also affected are 107,673 bottles of the 5 mg capsules, listed under NDC codes 0093-4069-01, 0093-4069-52, and 0093-4069-05. These were produced in multiple lots with expiration dates stretching into 2026.

Health authorities have advised patients to immediately discontinue the use of any affected products and also consult their healthcare provider as soon as possible.